| 摘要 |
Nanostructure-drug conjugates and associated methods of use are provided. In one embodiment, a nanostructure-drug conjugate comprising a C<SUB>n</SUB>, a crosslinker, and a drug is provided, wherein C<SUB>n </SUB>refers to a fullerene moiety or nanotube comprising n carbon atoms. A method of treating cancer is also provided, comprising administering a therapeutically effective amount of a nanostructure-drug conjugate comprising: a C<SUB>n</SUB>, a crosslinker, and a drug, wherein C<SUB>n </SUB>refers to a fullerene moiety comprising n carbon atoms to a mammal.
|
